Pharmacogenomics Corner

Back to articles

Pharmacogenetic-based decision tools are not interchangeable

KEY POINT

A comparison of four commercially available pharmacogenetic-based decision tools in patients with major depressive disorder (MDD) and numerous treatment failures showed that genotype and predicted phenotype agreement varied substantially, as did medication recommendations, indicating these tests cannot be considered equivalent or interchangeable.